You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for SERTRALINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


SERTRALINE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Almatica SERTRALINE HYDROCHLORIDE sertraline hydrochloride CAPSULE;ORAL 215133 NDA AUTHORIZED GENERIC Alvogen, Inc. 47781-951-30 30 CAPSULE in 1 BOTTLE (47781-951-30) 2025-09-18
Almatica SERTRALINE HYDROCHLORIDE sertraline hydrochloride CAPSULE;ORAL 215133 NDA AUTHORIZED GENERIC Alvogen, Inc. 47781-962-30 30 CAPSULE in 1 BOTTLE (47781-962-30) 2025-09-18
Almatica SERTRALINE HYDROCHLORIDE sertraline hydrochloride CAPSULE;ORAL 215133 NDA Almatica Pharma LLC 52427-664-30 30 CAPSULE in 1 BOTTLE (52427-664-30) 2021-10-04
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Sertraline Hydrochloride

Last updated: July 29, 2025

Introduction

Sertraline Hydrochloride is a widely prescribed selective serotonin reuptake inhibitor (SSRI) primarily used to treat depression, anxiety disorders, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD). Given its demand, a comprehensive understanding of its suppliers is critical for pharmaceutical manufacturers, healthcare providers, and regulatory agencies. This article examines global suppliers, manufacturing sources, and the supply chain landscape for Sertraline Hydrochloride.


Global Manufacturing and Supply Chain Overview

Sertraline Hydrochloride is produced through complex chemical synthesis processes, often in facilities compliant with Good Manufacturing Practices (GMP). Major pharmaceutical companies and active pharmaceutical ingredient (API) producers supply this compound globally, ensuring consistent quality and regulatory adherence. The market is characterized by a mix of large multinational manufacturers, regional generic producers, and specialty chemical suppliers, all contributing to a robust supply chain.


Major Suppliers and Manufacturers

1. Global Pharmaceutical Giants

Large pharmaceutical corporations dominate the supply chain, either manufacturing the brand-name drug or supplying APIs for generic versions. These include:

  • Pfizer Inc.
    Originally developed Sertraline in partnership with Pfizer, the drug was introduced under the brand name Zoloft. Pfizer remains an important player supplying the finished product but is less involved in raw API manufacturing nowadays.

  • Teva Pharmaceutical Industries Ltd.
    As one of the world's largest generic medication producers, Teva supplies Sertraline Hydrochloride APIs to multiple markets worldwide. They operate GMP-certified facilities capable of large-scale production of serotonergic API compounds.

  • Mylan N.V. (now part of Viatris)
    A major supplier of generic pharmaceuticals, Mylan produces Sertraline Hydrochloride APIs, primarily targeting markets in North America, Europe, and Asia.

2. API Manufacturers and Contract Manufacturing Organizations (CMOs)

Several specialized companies focus primarily on API synthesis and supply, often engaging in outsourcing manufacturing agreements:

  • Hetero Labs Limited (India)
    Hetero is a significant API manufacturer with GMP-certified plants offering Sertraline Hydrochloride. Their ability to supply at competitive prices makes them a key player in emerging markets.

  • Sun Pharmaceutical Industries Ltd.
    As one of India's largest pharmaceutical firms, Sun Pharma provides API manufacturing services, including Sertraline Hydrochloride, with a focus on quality and regulatory compliance.

  • Alvogen
    An emerging CMO, Alvogen offers API synthesis services and supplies Sertraline Hydrochloride to generic and private-label pharmaceutical firms.

  • Taj Pharmaceuticals Ltd.
    Based in India, Taj Pharmaceuticals is known for producing high-quality APIs, including Sertraline Hydrochloride, meeting both domestic and international regulatory standards.

3. Chinese API Producers

China remains a dominant player in the API market, including for SSRIs like Sertraline:

  • Shandong Xinhua Pharmaceutical Co.
    An established producer providing high-purity APIs, including Sertraline Hydrochloride, serving both domestic and export markets.

  • North China Pharmaceutical Group Corp. (NCPC)
    NCPC supplies various APIs, maintaining stringent quality measures aligned to international standards.

  • Zhejiang Hisun Pharmaceutical Co.
    Offers GMP-certified Sertraline Hydrochloride APIs for global markets, with a focus on affordability and compliance.

4. Regional and Local Suppliers

In addition to global suppliers, regional players in Latin America, Southeast Asia, and Eastern Europe supply Sertraline Hydrochloride. These suppliers often cater to generic drug manufacturers and compounding pharmacies.

Market Dynamics Impacting Supply

  • Regulatory Compliance: Suppliers must comply with GMP, FDA, EMA, and other regional standards, influencing the selection of API sources for regulatory approval.

  • Price Competition: Indian and Chinese suppliers often offer cost-competitive APIs, leading to an increased reliance on these sources for generics.

  • Supply Chain Risks: Disruptions from geopolitical issues, regulatory changes, or pandemic-related constraints impact the availability of Sertraline Hydrochloride from certain suppliers.

  • Quality Assurance: Suppliers with tested stability, high purity levels, and proven track records maintain market preference.


Supply Chain Challenges and Considerations

  1. Regulatory Approvals
    Suppliers must navigate complex international regulatory pathways, including DMF (Drug Master File) submissions, to supply Sertraline Hydrochloride for global markets.

  2. Traceability and Quality Control
    Ensuring traceability from raw material sourcing through manufacturing and packaging is vital for safety and regulatory compliance.

  3. Pricing Strategies
    Price fluctuations are influenced by raw material costs, manufacturing efficiencies, and geopolitical factors.

  4. Supply Security
    Dependence on specific regions (e.g., China and India) presents risks of shortages or delays.


Emerging Trends and Future Outlook

  • Diversification of Supply Sources: Companies are increasingly diversifying their supplier base to mitigate geopolitical risks and ensure supply continuity.

  • Shift towards Contract Manufacturing: The trend of outsourcing API synthesis to specialized CMOs continues to expand, facilitating scalability and cost reduction.

  • Enhanced Regulatory Oversight: Post-pandemic scrutiny enhances manufacturer transparency regarding manufacturing processes and supply chain integrity.

  • Sustainability Practices: Growing emphasis on sustainable manufacturing impacts supplier qualification and sourcing strategies.


Key Takeaways

  • The supply chain for Sertraline Hydrochloride predominantly involves multinational pharmaceutical companies, Indian, Chinese, and regional API manufacturers.

  • India and China are primary sources for cost-effective APIs, but suppliers must meet strict regulatory standards to ensure market access.

  • Quality assurance, regulatory compliance, and supply chain resilience are critical decision factors when selecting suppliers.

  • Diversification and robust supplier qualification programs mitigate risks associated with geopolitical and pandemic-related disruptions.

  • Ongoing market consolidation and technological innovation may influence procurement strategies for Sertraline Hydrochloride.


Frequently Asked Questions (FAQs)

1. Who are the leading global suppliers of Sertraline Hydrochloride API?
Major suppliers include Teva Pharmaceutical, Sun Pharma, Hetero Labs, and Chinese API producers like Shandong Xinhua Pharmaceutical. These companies supply high-quality, GMP-compliant APIs tailored for international markets.

2. How do Indian and Chinese API manufacturers compare in supplying Sertraline Hydrochloride?
Indian and Chinese API manufacturers offer competitive pricing, high-volume production, and compliance with international standards. However, buyers must conduct rigorous qualification to ensure quality, regulatory compliance, and supply reliability.

3. What regulatory challenges exist for sourcing Sertraline Hydrochloride API globally?
Regulatory challenges include obtaining necessary certifications (GMP, DMF), adhering to regional standards such as FDA and EMA requirements, and ensuring traceability and documentation support for rapid registration.

4. How does geopolitical stability influence supplier choices for Sertraline Hydrochloride?
Geopolitical issues, such as trade tensions or export restrictions, can disrupt supply chains. Diversifying suppliers across regions reduces dependence on a single geographical source, ensuring supply continuity.

5. What trends are shaping the future of Sertraline Hydrochloride supply?
The future includes increased reliance on contract manufacturing, sourcing diversification, and enhanced transparency in supply chain practices, driven by regulatory pressures and market demand for cost-effective yet reliable supplies.


References

  1. U.S. Food and Drug Administration. (2022). API Manufacturing and Quality Standards.
  2. GlobalData. (2023). Pharmacovigilance and API Market Trends Analysis.
  3. Indian Pharmaceutical Alliance. (2022). API Industry Overview.
  4. China Pharmacists Association. (2022). API Production and Market Dynamics.
  5. Industry Reports. (2023). Global SSRI API Supply Chain and Market Insights.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.